AD and PN: Diagnosis and Impact on Quality of Life
Approaches to diagnosis and the multidimensional burden of atopic dermatitis and prurigo nodularis – Highlight from the ADVENT symposium at AAD 2023.
Learning objectives
- Recognize characteristics and disease burden of atopic dermatitis (AD) and prurigo nodularis (PN)
- Describe how AD and PN are distinct diseases and how some patients may experience both
- Examine how type 2 inflammation drives pruritus and cutaneous tissue manifestations, thus playing a key role in both AD and PN pathophysiology
Description
In this ADVENT symposium at the 2023 AAD annual meeting, “Prurigo Nodularis and Atopic Dermatitis: Distinct Diseases With Shared and Unique Roles for Type 2 Inflammation”, Sarina Elmariah, MD, PhD, MPH (University of California San Francisco), Brian Kim, MD, MTR (Icahn School of Medicine at Mount Sinai), and Shawn Kwatra, MD (Johns Hopkins University School of Medicine), reviewed the clinical presentation and disease burden of prurigo nodularis (PN) and atopic dermatitis (AD), and the role that type 2 inflammation plays in the development of these two chronic pruritic diseases.
About this expert
Sarina Elmariah
Associate Professor and Dermatology Director at the UCSF Centre for Itch and Neurosensory Disorders at the University of California in San Francisco, California, US
See author’s profileRelated resources
